OmniBRx is an Ahmedabad-based bioprocess engineering company that designs and manufactures innovative, ISO-certified, and GMP-compliant single-use bioreactor platforms. The company caters to the biopharmaceutical and life sciences sectors with advanced bioprocessing equipment. It operates production and design facilities in India alongside a sales office in the United States.
Subscribe to see OmniBRx’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
OmniBRx is a biotechnology company headquartered in India. Its most recent funding round, Series A, raised $5M in March 2023. Xcout tracks 2 named people at OmniBRx, including Ravindra Patel (Chief Executive Officer).
As of 16 November 2026. Source: Xcout Intel.
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5M | 2 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of OmniBRx's closest competitors — see the full list of competitors and alternatives →
CellBri is a cell therapy automation company that develops closed-system, cGMP-ready platforms for manufacturing CAR-T, NK, TCR-T, and stem cells without vendor lock-in.
Shanghai OPM Biosciences Co., Ltd. provides high-performance cell culture media, custom media development, and end-to-end CRDMO and CRO services for biopharmaceutical and biologics companies. Its offerings support clients across the drug R&D lifecycle, from early discovery and cell line development through clinical and commercial manufacturing.
Biologics Modular, LLC designs and manufactures pre-constructed, container-based modular cleanrooms, biomanufacturing suites, and research facilities. The company serves pharmaceutical manufacturers, health science service providers, and educational institutions by providing scalable, transportable, and CGMP-validated production environments.
IRUBIS is a medical technology and life sciences company headquartered in Munich, Germany, specializing in mid-infrared spectroscopy for bioprocessing. The company has developed 'Monipa', an analytical instrument designed for real-time monitoring of bioprocesses in cell culture applications.
ChainReactor Technologies provides infrastructure for industrial biology by combining physical AI, process engineering, and patented advanced manufacturing. The company offers modular benchtop bioreactors and a large biological model to help biomanufacturers predict cell behavior and test processes at scale before commercial production.
Bioreactors.net is an innovative Latvian and European company that designs and manufactures laboratory, pilot, and industrial-scale bioreactors. Their systems feature advanced controls, novel magnetic drives, and fully automated production lines that meet diverse application needs while ensuring GMP compliance with SCADA software.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about OmniBRx? Suggest a correction · Work at OmniBRx? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.